PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Genomics & Informatics10.5808/gi.220512022203e29The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patientsChoong-kun Lee, Hong Jae Chon, Woo Sun Kwon, Hyo-Jeong Ban, Sang Cheol Kim, Hyunwook Kim, Hei-Cheul Jeung, Jimyung Chung, Sun Young Rhahttp://genominfo.org/upload/pdf/gi-22051.pdf, http://genominfo.org/journal/view.php?doi=10.5808/gi.22051, http://genominfo.org/upload/pdf/gi-22051.pdf
Cancer10.1002/cncr.339712021127224122-4123Pricing transparency among several needs for patients with high‐risk breast cancerAshley Hayhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33971, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cncr.33971, https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33971
BMJ10.1136/bmj.h41342015h4134Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western populationhttp://data.bmj.org/tdm/10.1136/bmj.h4134, https://syndication.highwire.org/content/doi/10.1136/bmj.h4134
Gastric Cancer10.1007/s10120-010-0553-42010133155-161Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trialMichael Gubanski, , Anders Johnsson, Eva Fernebro, Lianna Kadar, Ingegerd Karlberg, Petra Flygare, Åke Berglund, Bengt Glimelius, Pehr A. Lindhttp://link.springer.com/content/pdf/10.1007/s10120-010-0553-4.pdf, http://link.springer.com/article/10.1007/s10120-010-0553-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10120-010-0553-4
Pediatric Blood & Cancer10.1002/pbc.242052012602242-247Concurrent radiation with irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: A report on toxicity and efficacy from a prospective pilot phase II studyKavita V. Dharmarajan, Leonard H. Wexler, Suzanne L. Woldenhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.24205, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.24205, http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24205/fullpdf
Journal of Gastric Cancer10.5230/jgc.2022.22.e720222211Predicting the Bleeding Risk for Patients on Anticoagulant Therapy Prior to Gastric Endoscopic Submucosal DissectionJie-Hyun Kimhttps://jgc-online.org/pdf/10.5230/jgc.2022.22.e7, https://jgc-online.org/DOIx.php?id=10.5230/jgc.2022.22.e7, https://jgc-online.org/DOIx.php?id=10.5230/jgc.2022.22.e7
Gastric Cancer10.1007/s10120-006-0379-2200693203-207Combination chemotherapy with irinotecan and cisplatin in pretreated patients with unresectable or recurrent gastric cancerShinya Ueda, Shuichi Hironaka, Narikazu Boku, Akira Fukutomi, Takayuki Yoshino, Yusuke Onozawahttp://link.springer.com/content/pdf/10.1007/s10120-006-0379-2.pdf, http://link.springer.com/article/10.1007/s10120-006-0379-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10120-006-0379-2
Gastric Cancer10.1007/s10120-011-0030-82011143226-233A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial)Tetsuya Hamaguchi, , Kuniaki Shirao, Atsushi Ohtsu, Ichinosuke Hyodo, Yasuaki Arai, Hiroya Takiuchi, Hirofumi Fujii, Motoki Yoshida, Hiroshi Saito, Tadamichi Denda, Wasaburo Koizumi, Hiroaki Iwase, Narikazu Bokuhttp://link.springer.com/content/pdf/10.1007/s10120-011-0030-8.pdf, http://link.springer.com/article/10.1007/s10120-011-0030-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10120-011-0030-8, http://link.springer.com/content/pdf/10.1007/s10120-011-0030-8.pdf
Medical Oncology10.1007/s12032-013-0630-82013303Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patientsJing Gao, Jun Zhou, Yanyan Li, Zhi Peng, Yilin Li, Xicheng Wang, Lin Shenhttp://link.springer.com/content/pdf/10.1007/s12032-013-0630-8.pdf, http://link.springer.com/article/10.1007/s12032-013-0630-8/fulltext.html, http://link.springer.com/content/pdf/10.1007/s12032-013-0630-8
British Journal of Cancer10.1038/sj.bjc.66044612008992275-282UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group studyD M Kweekel, H Gelderblom, T Van der Straaten, N F Antonini, C J A Punt, H-J Guchelaarhttp://www.nature.com/articles/6604461.pdf, http://www.nature.com/articles/6604461, http://www.nature.com/articles/6604461.pdf